13.01.2014 Views

0-TESTO COMPLETO.pdf - Fondazione Santa Lucia

0-TESTO COMPLETO.pdf - Fondazione Santa Lucia

0-TESTO COMPLETO.pdf - Fondazione Santa Lucia

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Sezione III: Attività per progetti<br />

U.O.4 – Laboratorio di Neurofisiologia<br />

Diego Centonze<br />

Specific contribution of the unit to the project<br />

The classical divide between degenerative and inflammatory disorders of<br />

the CNS is vanishing, as our understanding on the intimate nature of several<br />

disease conditions is improving. Inflammatory processes play an important<br />

role in the pathophysiology of primarily degenerative disorders such as HD<br />

and ALS, and neurodegeneration complicates primarily inflammatory diseases<br />

of the brain and spinal cord such as multiple sclerosis (MS). Microglia<br />

is emerging as a fundamental player in the crosstalk between inflammation<br />

and neurodegeneration, since it is activated by both processes and boost, in<br />

turn, both neuroinflammation and neurodegeneration. An apparently unique<br />

opportunity to interfere at once with neurodegeneration and neuroinflammation<br />

processes originates from the modulation of the endocannabinoid system<br />

(ECS). Accordingly, central neurons and immune cells possess the biochemical<br />

machinery required for endocannabinoid synthesis, transport and degradation,<br />

and respond to the stimulation of cannabinoid CB1 and CB2 receptors<br />

by changing their physiological activity. In neurons, cannabinoid may regulate<br />

both excitatory and inhibitory transmission through pre- and postsynaptic<br />

mechanisms, while in immune cells and in microglia, the activation of<br />

cannabinoid receptors significantly alters their metabolic activity and<br />

responses during inflammation.<br />

Based on these considerations, in the present research project we aim at<br />

clarifying the role of microglia and of the ECS system in the pathophysiology<br />

of experimental HD, ALS and MS. In particular, since changes of both excitatory<br />

and inhibitory transmission represent early events triggering secondary<br />

excitotoxicity and inflammatory neurodegeneration, we will measure synaptic<br />

transmission in the three models of inflammatory neurodegeneration by<br />

means of neurophysiological recordings in corticostriatal brain slices during<br />

the modulation of the ECS. A peculiar susceptibility of the corticostriatal system<br />

in HD, ALS and MS, in fact, has been convincingly documented. The role<br />

of microglia in the possible changes of synaptic transmission induced by<br />

these disorders will be investigated by direct incubation of corticostriatal<br />

slices with quiescent and activated microglial cells, as well as with cytokines<br />

produced by microglia.<br />

Methods<br />

The effects of pharmacological modulation of cannabinoid system will be<br />

investigated in experimental HD, ALS and MS and in their respective controls.<br />

In particular, we will perform in vitro whole-cell patch clamp electrophysiological<br />

recordings in corticostriatal brain slices prepared from mouse<br />

models of HD (R6/2 mutant mice; Jackson Laboratories, Bar Harbor, ME,<br />

USA), ALS (B6SJL-TgN(SOD1-G93A)1Gur mice, Jackson Laboratories, Bar<br />

750 2009

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!